What does APOTHEEK PYLYSER SOFIE do?

APOTHEEK PYLYSER SOFIE is a pharmacy in Alveringem. Private Limited, started on 30 March 2007, 1 establishment.

What is the address of APOTHEEK PYLYSER SOFIE?

The registered office of APOTHEEK PYLYSER SOFIE is located at Izenbergestraat 57, 8691 Alveringem.

Is APOTHEEK PYLYSER SOFIE still active?

Yes. According to the CBE (30 October 2026) APOTHEEK PYLYSER SOFIE is active, legal situation “Normale toestand”, started on 30 March 2007.

Is APOTHEEK PYLYSER SOFIE registered on Peppol?

Yes, APOTHEEK PYLYSER SOFIE is registered on the Peppol network with ID 0208:0888396472.

What is the enterprise number of APOTHEEK PYLYSER SOFIE?

The enterprise number of APOTHEEK PYLYSER SOFIE is BE0888396472.

When was APOTHEEK PYLYSER SOFIE founded?

APOTHEEK PYLYSER SOFIE was founded on 30 March 2007.

Who are the directors of APOTHEEK PYLYSER SOFIE?

According to the 2025 annual accounts, the directors of APOTHEEK PYLYSER SOFIE are: Ophira BV.

Is APOTHEEK PYLYSER SOFIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 March 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PYLYSER SOFIE make in 2025?

APOTHEEK PYLYSER SOFIE posted a profit after taxes of € 58,214 in financial year 2025.

What is the revenue of APOTHEEK PYLYSER SOFIE?

As a small company, APOTHEEK PYLYSER SOFIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 80,857.

APOTHEEK PYLYSER SOFIE (Private Limited) - Alveringem

Dossier APOTHEEK PYLYSER SOFIE, printed on 30 October 2026 from databakkes.be/en/0888396472/apotheek-pylyser-sofie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK PYLYSER SOFIE from Alveringem, company number BE0888396472, closed financial year 2025 with a result of € 58,214 after tax. For that financial year APOTHEEK PYLYSER SOFIE recorded a gross margin of € 80,857 and equity of € 84,627. Compared with financial year 2024, the result moved from € 50,386 to € 58,214. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Healthy

€ 84,627

▼ 42% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 58,214

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 14,177

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 2,844

▲ 214% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 25,635

▲ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,185

▲ 18% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 9,834 Gross margin 2022: € 9,834 First fiscal year in the series	€ 42,912 Gross margin 2023: € 42,912 ▲ € 33,078 vs 2022 (€ 9,834) Favourable step	€ 75,879 Gross margin 2024: € 75,879 ▲ 77% vs 2023 (€ 42,912) Favourable step	€ 80,857 Gross margin 2025: € 80,857 ▲ 7% vs 2024 (€ 75,879) Favourable step	▲ 7%
Profit after taxes	€ 7,546 Profit after taxes 2022: € 7,546 First fiscal year in the series	€ 22,761 Profit after taxes 2023: € 22,761 ▲ 202% vs 2022 (€ 7,546) Favourable step	€ 50,386 Profit after taxes 2024: € 50,386 ▲ 121% vs 2023 (€ 22,761) Favourable step	€ 58,214 Profit after taxes 2025: € 58,214 ▲ 16% vs 2024 (€ 50,386) Favourable step	▲ 16%
Equity	€ 73,266 Equity 2022: € 73,266 First fiscal year in the series	€ 96,027 Equity 2023: € 96,027 ▲ 31% vs 2022 (€ 73,266) Favourable step	€ 146,413 Equity 2024: € 146,413 ▲ 52% vs 2023 (€ 96,027) Favourable step	€ 84,627 Equity 2025: € 84,627 ▼ 42% vs 2024 (€ 146,413) Unfavourable step	▼ 42%
Total debts	€ 176,504 Total debts 2022: € 176,504 First fiscal year in the series	€ 186,611 Total debts 2023: € 186,611 ▲ 6% vs 2022 (€ 176,504) Unfavourable step	€ 149,016 Total debts 2024: € 149,016 ▼ 20% vs 2023 (€ 186,611) Favourable step	€ 230,279 Total debts 2025: € 230,279 ▲ 55% vs 2024 (€ 149,016) Unfavourable step	▲ 55%
Cash	€ 9,736 Cash 2022: € 9,736 First fiscal year in the series	€ 10,737 Cash 2023: € 10,737 ▲ 10% vs 2022 (€ 9,736) Favourable step	€ 17,790 Cash 2024: € 17,790 ▲ 66% vs 2023 (€ 10,737) Favourable step	€ 14,177 Cash 2025: € 14,177 ▼ 20% vs 2024 (€ 17,790) Unfavourable step	▼ 20%
Retained profit	€ 43,266 Retained profit 2022: € 43,266 First fiscal year in the series	€ 66,027 Retained profit 2023: € 66,027 ▲ 53% vs 2022 (€ 43,266) Favourable step	€ 116,413 Retained profit 2024: € 116,413 ▲ 76% vs 2023 (€ 66,027) Favourable step	€ 54,627 Retained profit 2025: € 54,627 ▼ 53% vs 2024 (€ 116,413) Unfavourable step	▼ 53%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 120,000 Dividend 2025: € 120,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 249,770 Balance sheet total 2022: € 249,770 First fiscal year in the series	€ 282,638 Balance sheet total 2023: € 282,638 ▲ 13% vs 2022 (€ 249,770) Unchanged	€ 295,429 Balance sheet total 2024: € 295,429 ▲ 5% vs 2023 (€ 282,638) Unchanged	€ 314,905 Balance sheet total 2025: € 314,905 ▲ 7% vs 2024 (€ 295,429) Unchanged	▲ 7%

Key figures of APOTHEEK PYLYSER SOFIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PYLYSER SOFIE?

What happened at APOTHEEK PYLYSER SOFIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 58,214 (▲ 16% vs 2024). Source: NBB ↗
Apr 1, 2007 New establishment in Alveringem. KBO
Mar 30, 2007 Start of the company according to the CBE. KBO

In short

From € 7,546 profit in 2022 to € 58,214 profit in 2025.

Paid € 39,167 in corporate taxes since 2022.

Best year ever: 2025, with € 58,214 profit.

Paid out € 120,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

OPHIRA 100%

The stake of OPHIRA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PYLYSER SOFIE

Behind APOTHEEK PYLYSER SOFIE is Ophira BV. The shares are held by OPHIRA (100%).

Directors

According to the 2025 annual accounts

Ophira BV

Director · represented by Pylyser Sofie

Shareholders

OPHIRA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Izenbergestraat 57

8691 Alveringem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

LOEDCO

€ 52,833 gross margin · 2025

GROEP PYLYSER

OPHIRA same network

€ 44,989 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0888.396.472

VAT number

BE 0888.396.472

Registered office

Izenbergestraat 57, 8691 Alveringem

Names & denominations

APOTHEEK PYLYSER SOFIE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 March 2007

Peppol

Active · Active since 14 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PYLYSER SOFIE

Financials

What happened to APOTHEEK PYLYSER SOFIE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions